What is the Historical Analysis of the Cell & Gene Therapy Manufacturing Services Market Size?
The cell & gene therapy manufacturing services market has seen considerable growth due to a variety of factors.
•Recent years have seen a fast-paced expansion in the size of the cell & gene therapy manufacturing services market. The market value, which is projected to rise from $8.15 billion in 2024 to reach $9.46 billion in 2025 at a compound annual growth rate (CAGR) of 16.1%.
can be traced back to a surge in R&D investments, strengthened regulatory support and frameworks, an expanding pipeline of cell & gene therapies, enhanced industry collaborations and partnerships, along with a rising global demand for personalized medicine.
What is the Forecasted Growth of the Cell & Gene Therapy Manufacturing Services Market Size?
The cell & gene therapy manufacturing services market is expected to maintain its strong growth trajectory in upcoming years.
• The market for manufacturing services in cell and gene therapy is projected to witness speedy expansion in the impending years, surging to a valuation of $17.97 billion in 2029, with a Compound Annual Growth Rate (CAGR) of 17.4%.
This augmentation in the predicted phase can be credited to market development and commercial acceptance, worldwide proliferation of biopharmaceutical manufacturing, heightened outsourcing from pharmaceutical firms, advancements in automation and robotics, and the arrival of innovative therapeutic modalities. The forthcoming period will also see trends like increased need for energy efficiency, sophisticated materials and technologies, compact and modular designs, electrification of transportation along with an intensified emphasis on safety and reliability.
What Key Factors and Trends are Driving the Growth of the Cell & Gene Therapy Manufacturing Services Market?
The surging cases of cancer and other specific diseases are expected to fuel the expansion of the cell and gene therapy manufacturing services market in the future. Cancer is a critical illness characterized by the rapid and uncontrolled multiplication and growth of the body's cells. The emergence of cell and gene therapies provides encouraging new approaches to deal with the escalating incidence of cancer, thereby boosting the need for innovative and effective treatment options. For example, as per reports from the American Cancer Society, a nonprofit cancer advocacy organization based in the US, there was a 3.16% rise in cancer cases in January 2023, increasing from 1,898,160 in 2021 to 1,958,310. Thus, the increasing incidence of cancer and other specific diseases contributes to propelling the future growth of the cell and gene therapy manufacturing services market.
What are the Market Segments in the Cell & Gene Therapy Manufacturing Services Market?
The cell & gene therapy manufacturing services market covered in this report is segmented –
1) By Type: Gene Therapy, Cell Therapy
2) By Indication: Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopedic Diseases, Oncology Diseases
3) By Application: Commercial Manufacturing, Clinical Manufacturing
4) By End-user: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users
Subsegments:
1) By Gene Therapy: Viral Vector Manufacturing, Plasmid DNA Production, Gene Editing Services, Formulation And Fill-Finish Services
2) By Cell Therapy: Cell Sourcing And Banking, Cell Processing And Expansion, Quality Control And Testing Services, Cryopreservation And Storage Services
Pre-Book The Cell & Gene Therapy Manufacturing Services Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends are Shaping the Cell & Gene Therapy Manufacturing Services Market?
The cell and gene therapy manufacturing services market is increasingly influenced by technological innovations. To maintain their market presence, many key players are integrating new technologies into their operations. For example, Charles River Laboratories International Inc., an American pharmaceutical company with specializations in multiple preclinical and clinical laboratory, gene therapy, and cell therapy services, introduced the navigation Vector Platform (navigation) in October 2022. The platform is designed to facilitate the path to GMP Adeno-Associated Virus (AAV) vector manufacturing without the need for in-depth process development. The navigation platform can significantly reduce the timeframe to GMP for viral vector gene therapy researchers by 55% when compared to traditional manufacturing workflows. The navigation method employed by Charles River relies on a uniquely productive HEK293 suspension cell line, capable of scaling and serotyping to fulfill client requirements.
Who Are the Key Players in the Cell & Gene Therapy Manufacturing Services Market?
Major companies operating in the cell & gene therapy manufacturing services market include:
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Charles River Laboratories International Inc.
• Lonza Group AG
• Catalent Inc.
• WuXi AppTec
• Takara Bio Inc.
• Nikon Corporation
• Fujifilm Holdings Corporation
• F. Hoffmann-La Roche Ltd
• Oxford Biomedica plc
• CGT Catapult
• bluebird bio Inc.
• Boehringer Ingelheim International GmbH
• Innovative Cellular Therapeutics Co. Ltd.
• Samsung Biologics Co. Ltd.
• Novartis International AG
• Pfizer Inc.
• Brammer Bio
• AGC Biologics
• Cognate BioServices Inc.
• Paragon Bioservices Inc.
• Merck KGaA operating as MilliporeSigma
• Sarepta Therapeutics Inc.
• Spark Therapeutics Inc.
• Orchard Therapeutics plc
• Precision BioSciences Inc.
• PCT a Hitachi Group Company
• Aldevron LLC
• BioNTech SE
What are the Regional Insights into the Cell & Gene Therapy Manufacturing Services Market?
North America was the largest region in the cell and gene therapy manufacturing services market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global cell & gene therapy manufacturing services market report forecast period. The regions covered in the cell & gene therapy manufacturing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
